DK166479C - Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning - Google Patents

Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning

Info

Publication number: DK166479C
Authority: DK; Denmark
Prior art keywords: norfluoxetin; fluoxetin; anxiolytical; medicine; preparation
Prior art date: 1983-04-08

Application number

DK113284A

Other languages

English (en)

Other versions

DK113284D0 (da

DK113284A (da

DK166479B (da

Inventor

Paul Stark

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-04-08

Filing date

1984-02-28

Publication date

1993-10-18

1984-02-28 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1984-02-28 Publication of DK113284D0 publication Critical patent/DK113284D0/da

1984-10-09 Publication of DK113284A publication Critical patent/DK113284A/da

1993-06-01 Publication of DK166479B publication Critical patent/DK166479B/da

1993-10-18 Application granted granted Critical

1993-10-18 Publication of DK166479C publication Critical patent/DK166479C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK113284A 1983-04-08 1984-02-28 Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning DK166479C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/483,087 US4590213A (en)	1983-04-08	1983-04-08	Anti-anxiety method
US48308783		1983-04-08

Publications (4)

Publication Number	Publication Date
DK113284D0 DK113284D0 (da)	1984-02-28
DK113284A DK113284A (da)	1984-10-09
DK166479B DK166479B (da)	1993-06-01
DK166479C true DK166479C (da)	1993-10-18

Family

ID=23918597

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK113284A DK166479C (da)	1983-04-08	1984-02-28	Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning

Country Status (9)

Country	Link
US (1)	US4590213A (da)
EP (1)	EP0123469B1 (da)
JP (1)	JPH0635382B2 (da)
AU (1)	AU556476B2 (da)
DE (2)	DE3413093A1 (da)
DK (1)	DK166479C (da)
GB (1)	GB2137496B (da)
IT (1)	IT1175977B (da)
ZA (1)	ZA842457B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4824868A (en) *	1982-09-07	1989-04-25	Ciba-Geigy Corporation	Propylamine derivatives useful for the treatment of dementia
EP0294028B1 (en) *	1987-05-04	1993-09-01	Eli Lilly And Company	Fluoxetine useful for the treatment of diabetes
US4971998A (en) *	1987-10-22	1990-11-20	Massachusetts Institute Of Technology	Methods for treating the premenstrual or late luteal phase syndrome
EP0386117B1 (en) *	1987-10-22	1999-01-07	Massachusetts Institute Of Technology	Treating premenstrual or late luteal phase syndrome
US5223540A (en) *	1987-10-22	1993-06-29	Massachusetts Institute Of Technology	Method for treating the premenstrual or late luteal phase syndrome
US5114976A (en) *	1989-01-06	1992-05-19	Norden Michael J	Method for treating certain psychiatric disorders and certain psychiatric symptoms
PT98628A (pt) *	1990-08-09	1992-06-30	Massachusetts Inst Technology	Processo de composicoes farmaceuticas a base de por exemplo sertralina
US5104899A (en) *	1990-08-13	1992-04-14	Sepracor, Inc.	Methods and compositions for treating depression using optically pure fluoxetine
US5589511A (en) *	1990-08-13	1996-12-31	Sepracor Inc.	Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
US6512010B1 (en)	1996-07-15	2003-01-28	Alza Corporation	Formulations for the administration of fluoxetine
US5830500A (en) *	1996-07-22	1998-11-03	Pentech Pharmaceuticals, Inc.	Low dose fluoxetine tablet
US6203817B1 (en)	1997-02-19	2001-03-20	Alza Corporation	Reduction of skin reactions caused by transdermal drug delivery
AU757973B2 (en) *	1998-11-23	2003-03-13	Sepracor, Inc.	Desmethylolanzapine compositions and methods
US7034059B2 (en) *	2001-07-02	2006-04-25	Sepracor Inc.	Methods of using norfluoxetine
US20040235906A1 (en) *	2001-08-08	2004-11-25	Gouliaev Alex Haahr	Substituted amine derivatives and their use as monoamine neurotransmitter re-up-take inhibitors
US20040034106A1 (en) *	2001-11-06	2004-02-19	Read Holly Ann	Treatment of anxiety disorders
US9138430B2 (en) *	2007-12-27	2015-09-22	Mylan Specialty L.P.	Formulation and method for the release of paroxetine in the large intestine
JP5299430B2 (ja) *	2008-09-30	2013-09-25	アイシン・エィ・ダブリュ株式会社	自動変速機
US20150174083A1 (en)	2012-07-31	2015-06-25	Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi	Use of fluoxetine for increasing meat and milk production
WO2014021801A1 (en)	2012-07-31	2014-02-06	Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret A.S.	Use of fluoxetine in animals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4194009A (en) *	1974-01-10	1980-03-18	Eli Lilly And Company	Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4313896A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Aryloxyphenylpropylamines
US4314081A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Arloxyphenylpropylamines
US4018895A (en) *	1974-01-10	1977-04-19	Eli Lilly And Company	Aryloxyphenylpropylamines in treating depression
US4329356A (en) *	1980-10-31	1982-05-11	Eli Lilly And Company	Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane

1983
- 1983-04-08 US US06/483,087 patent/US4590213A/en not_active Expired - Lifetime
1984
- 1984-02-28 DK DK113284A patent/DK166479C/da active
- 1984-04-02 ZA ZA842457A patent/ZA842457B/xx unknown
- 1984-04-03 JP JP59067310A patent/JPH0635382B2/ja not_active Expired - Lifetime
- 1984-04-05 AU AU26457/84A patent/AU556476B2/en not_active Ceased
- 1984-04-06 DE DE19843413093 patent/DE3413093A1/de not_active Withdrawn
- 1984-04-06 GB GB08408880A patent/GB2137496B/en not_active Expired
- 1984-04-06 EP EP84302361A patent/EP0123469B1/en not_active Expired
- 1984-04-06 IT IT20432/84A patent/IT1175977B/it active
- 1984-04-06 DE DE8484302361T patent/DE3467704D1/de not_active Expired

Also Published As

Publication number	Publication date
IT8420432A1 (it)	1985-10-06
EP0123469B1 (en)	1987-11-25
US4590213A (en)	1986-05-20
ZA842457B (en)	1985-11-27
GB2137496B (en)	1986-10-01
DE3467704D1 (en)	1988-01-07
JPS59193821A (ja)	1984-11-02
DK113284D0 (da)	1984-02-28
EP0123469A1 (en)	1984-10-31
JPH0635382B2 (ja)	1994-05-11
IT1175977B (it)	1987-08-12
GB2137496A (en)	1984-10-10
DE3413093A1 (de)	1984-10-11
AU556476B2 (en)	1986-11-06
IT8420432A0 (it)	1984-04-06
AU2645784A (en)	1984-10-11
GB8408880D0 (en)	1984-05-16
DK113284A (da)	1984-10-09
DK166479B (da)	1993-06-01

Similar Documents

Publication	Publication Date	Title
DK253988A (da)	1988-11-16	Farmaceutisk praeparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden
DK166479C (da)	1993-10-18	Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
DK156376C (da)	1990-01-02	Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK146482A (da)	1982-10-07	Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK74282A (da)	1982-08-28	Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
IT8267184A0 (it)	1982-02-19	Bendaggio per la somministrazione di medicamenti
DK161968C (da)	1992-02-03	Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK163181C (da)	1992-06-22	Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
DK645788A (da)	1989-05-21	Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO157506C (no)	1988-03-30	Fremgangsmaate for fremstilling av human-insulin eller treoninb30-derivater av human-insulin eller et salt eller kompleks derav.
DK158658C (da)	1990-12-31	Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK151805C (da)	1988-06-13	Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK321482A (da)	1983-01-19	Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK232777A (da)	1977-12-16	Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK473088A (da)	1989-02-26	Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288D0 (da)	1988-08-24	Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK386783A (da)	1984-02-25	Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf
DK15282A (da)	1982-08-27	Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK232877A (da)	1977-12-16	Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK149823C (da)	1987-03-16	Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK586284D0 (da)	1984-12-07	Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK150481C (da)	1987-09-28	Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf
DK302887A (da)	1987-12-17	Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK346181A (da)	1982-02-06	Fremgangsmaade til fremstilling af pyrazolobenzazepiner eller farmaceutisk acceptable salte deraf
DK163300C (da)	1992-07-13	Analogifremgangsmaade til fremstilling af fluorerede alkandiaminderivater eller pharmaceutisk acceptable salte deraf